| May 21, 2019 |
Division of Corporation Finance
Securities and Exchange Commission
100 F. Street, NE
Washington, DC 20549
Attention: Jeffrey Gabor
Re: Trovagene, Inc.
Post-Effective Amendment No. 3 to Form S-1
Filed May 17, 2019
File No. 333-224808
Dear Mr. Gabor:
This letter sets forth the response of Trovagene, Inc., a Delaware corporation (the “Company” or “we”), to the comment received from the Staff of the Division of Corporation Finance (the “Staff”) of the Securities and Exchange Commission (the “Commission”) by letter dated May 20, 2019 (“Comments Letter”) concerning the Company’s Post-Effective Amendment No. 3 to Form S-1 (the “Registration Statement”).
Post-Effective Amendment No. 3 to Form S-1
General
1. Please revise to include a complete prospectus that includes all of the disclosure items required by Part I. Refer to Securities Act Rule 472(b).
Response: We have revised Post-Effective Amendment No. 3 to Form S-1 to include a complete prospectus.
* * * *
If you have any further comments and/or questions, please contact me at (212) 634-3067.
| Very truly yours, |
|
|
| /s/ Jeffrey Fessler |
